Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 21, 2011; 17(15): 2028-2036
Published online Apr 21, 2011. doi: 10.3748/wjg.v17.i15.2028
Published online Apr 21, 2011. doi: 10.3748/wjg.v17.i15.2028
Table 3 Relationship between marker expression and clinical features (P values)
Markers | P values | |||||
Differentiation | pT | pN | pM | TNM | Post-surgery | |
P53 | 0.671 | 0.654 | 0.003b | 0.119 | 0.024a | 0.207 |
MAPK | 0.186 | 0.597 | 0.230 | 0.188 | 0.182 | 0.001b |
E-cadherin | 0.028a | 0.342 | 0.080 | 0.041a | 0.223 | 0.004b |
MSH2 | 0.964 | 0.006b | 0.012a | 0.061 | 0.001b | 0.001b |
ADCY-2 | 0.458 | 0.430 | 0.779 | 0.470 | 0.878 | 0.082 |
Shp2 | 0.020a | 0.004b | 0.035a | 0.849 | 0.006b | 0.006b |
SPARCL1 | 0.002b | 0.171 | 0.037a | 0.021a | 0.044a | 0.014a |
- Citation: Yu SJ, Yu JK, Ge WT, Hu HG, Yuan Y, Zheng S. SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer. World J Gastroenterol 2011; 17(15): 2028-2036
- URL: https://www.wjgnet.com/1007-9327/full/v17/i15/2028.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i15.2028